Quantcast

Latest Willebrand Stories

2014-03-26 20:21:45

SPOKANE, Wash., March 26, 2014 /PRNewswire/ -- Paw Print Genetics, a division of Genetic Veterinary Sciences, Inc. and VetGen, a Michigan-based company have decided to forego litigation and have reached a settlement related to the patent lawsuit filed by Paw Print Genetics. The patents are held by the University of Michigan and Michigan State University and are licensed to VetGen for canine genetic testing related to von Willebrand Disease. Paw Print Genetics will begin offering...

2012-06-21 23:03:15

Strategic focus and robust portfolio of services continue to create record distribution trend for specialty biotech distributor BDI Pharma. Columbia, SC (PRWEB) June 21, 2012 BDI Pharma, Inc. (BDI), the nation´s fastest growing national distributor of biotech therapies, after finishing the previous calendar year with a record level of distribution in anti-hemophilic factor (AHF), announced today that through the first five (5) months of 2012, the company´s distribution is tracking...

2011-11-01 07:00:00

The Bio Magazine Eurekamag.com publishes reviews on a wide range of topics within the biological sciences. The magazine publishes 1-4 such reviews every day and the latest inclusions cover the West Nile Virus and Von Willebrand Disease. (PRWEB) November 01, 2011 The Science Magazine EurekaMag.com covers a wide range of topics including biology, agriculture, horticulture, forestry, geography, environment and health. Drawing from this pool of scientific disciplines, it publishes reviews on...

2011-01-25 13:14:29

Thrombotic thrombocytopenic purpura (TTP) is a life-threatening disease of the blood system. The condition is caused by the presence of ultralarge multimers of the protein von Willebrand factor, which promote the formation of blood clots (thrombi) in small blood vessels throughout the body. Current treatments are protracted and associated with complications. However, a team of researchers, led by Jos© L³pez, at the Puget Sound Blood Center, Seattle, has generated data in mice that...

2011-01-25 00:02:23

Octapharma has been committed to innovative patient care programs since inception and industry partnerships are central to the biopharmaceutical company's mission. As the most common inherited bleeding disorder in humans, von Willebrand Disease (VWD) affects one to two percent of the general population or approximately 3 million people in the United States. The severity of VWD is highly variable, from severe cases in which the tendency for excessive bleeding is obvious and treatment...

2010-12-08 09:30:00

HOBOKEN, N.J., Dec. 8, 2010 /PRNewswire/ -- Octapharma USA researchers presented new stringent, objective criteria used in the evaluation of hemostatic efficacy in the treatment of von Willebrand disease (VWD) and reported on their application of these criteria in clinical trials during the recently completed National Hemophilia Foundation (NHF) Annual Meeting. According to the National Institutes of Health VWD is the most common inherited bleeding disorder and occurs in about 1 out of...

2010-11-17 00:00:51

Music Video Kicked Off Initiative to Raise Awareness of Blood Disorders in Women New York (PRWEB) November 16, 2010 The National Hemophilia Foundation (NHF) launched its new initiative, Victory for Women, at their 62nd Annual Meeting in New Orleans, November 11 through 13. Since most women affected by the most common hereditary bleeding disorder, von Willebrand disease (VWD), don't even know they have it, the campaign is designed to generate awareness outside of the bleeding community and...


Word of the Day
snash
  • To talk saucily.
  • Insolent, opprobrious language; impertinent abuse.
This word is Scots in origin and probably imitative.